A study of the mean concentration of plasma antithrombin IIi in arterial hypertension in pregnancy
Berardi, J.C.; Rouchon, M.H.; Laloux, V.; Akli, J.; Berardi Grassias, L.
Revue Francaise de Gynecologie et d'Obstetrique 79(11): 709-712
1984
ISSN/ISBN: 0035-290X PMID: 6533744 Document Number: 226721
Plasma antithrombin III (AT III) level was examined in 30 pregnant women with hypertension and 44 without hypertension. AT III level is significatively lower in the group of hypertension. The degree of reduction in plasma AT III level seems to be correlated with hyper uricemia but not with count of platelets or fibrinogen.
Document emailed within 1 workday
Related Documents
Teng, Y.-c.; Tang, X.-w.; Lin, Q.-d.; Wu, Y.-x.; Song, X.-l. 2003: Relationship between left ventricular diastolic function and plasma brain natriuretic peptide concentration during severe pregnancy-induced hypertension syndrome Zhonghua Yi Xue Za Zhi 83(8): 662-665Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Weiner, C.P.; Kwaan, H.C.; Xu, C.; Paul, M.; Burmeister, L.; Hauck, W. 1985: Antithrombin IIi activity in women with hypertension during pregnancy Obstetrics and Gynecology 65(3): 301-306
Sherman, R.C.; Burdge, G.C.; Ali, Z.; Singh, K.L.; Wootton, S.A.; Jackson, A.A. 2001: Effect of pregnancy on plasma lipid concentration in Trinidadian women. Result of a pilot study West Indian Medical Journal 50(4): 282-287
Tomashets, E.A.; Mazur, N.A.; Masenko, V.P. 1992: The dynamics of the concentration of atrial natriuretic factor depending on changes in the arterial pressure level in patients with arterial hypertension Terapevticheskii Arkhiv 64(4): 12-15
Chełchowska, M.; Gajewska, J.; Ambroszkiewicz, J.; Laskowska-Klita, T.; Bulska, E.Joanna.; Leibschang, J.; Szymański, M.; Barciszewski, J. 2008: The influence of lead on concentration of the pregnancy-associated plasma protein A (PAPP-A) in pregnant women smoking tobacco--preliminary study Przeglad Lekarski 65(10): 470-473
Zhou, Q.; Sun, M.; Zhou, H. 1999: Study on the relationship between plasma endothelin nitric oxide concentration and renal hypertension and renal function Hunan Yi Ke da Xue Xue Bao 24(4): 381-383
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Gryboś, M.; Krzemieniewska, J.; Stacherzak-Pawlik, J.; Wilczyński, A.; Woźniak, M.ła.; Majsnerowicz, M.; Gryboś-Jagielska, A. 2005: Total and ionized magnesium concentration in the blood plasma and erythrocytic magnesium concentration of women in the third trimester of pregnancy with imminent preterm labor Ginekologia Polska 76(8): 625-631
Jendryczko, A.; Tomala, J. 1993: Increase of hemoglobin concentration in blood during the second trimester of pregnancy in relation to later pregnancy complications such as hypertension and intrauterine fetal growth inhibition Wiadomosci Lekarskie 46(5-6): 201-205
Zebrowska-Lupina, I.; Kolber-Postepska, B.; Markiewicz, M.; Horubała-Bielak, G. 1994: Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension Wiadomosci Lekarskie 47(7-8): 241-247
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Brown, M.A.; McCowan, L.M.; North, R.A.; Walters, B.N. 1997: Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy Medical Journal of Australia 166(12): 640-643
Masson, G.M.; Klopper, A.I.; Wilson, G.R. 1977: Plasma estrogens and pregnancy-associated plasma proteins: a study of their variability in late pregnancy Obstetrics and Gynecology 50(4): 435-438
Metelitsa, V.I.; Filatova, N.P. 1991: The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy Terapevticheskii Arkhiv 63(8): 30-34
Weaver, K. 1989: Erythrocyte and plasma magnesium during teenage pregnancy: relationship with blood pressure and pregnancy-induced hypertension Obstetrics and Gynecology 74(1): 135-137
Selivonenko, V.G.; Morozov, A.I. 1985: Concentration of somatotropic hormone in the blood in arterial hypertension of different origin Kardiologiia 25(12): 85-87
Kolloch, R.; Stumpe, K.O.; Higuchi, M.; Vetter, H.; Glänzer, K.; Krück, F. 1977: Elevated plasma prolactin concentration in essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 296-298
Zhang, W.; Zhao, Y.; Wang, L. 1998: The changes of plasma calcitonin gene-related peptide level in women with normal pregnancy and pregnancy induced hypertension Zhonghua Fu Chan Ke Za Zhi 33(12): 715-716